Home▸Psilocybin/MDMA-Assisted Therapy▸FDA Breakthrough Therapy Designation Pathway Simulator

🍄 FDA Breakthrough Therapy Designation Pathway Simulator

This simulation guides users through the process of obtaining a Breakthrough Therapy Designation from the FDA for psychedelic drugs, highlighting critical steps and requirements.

Psilocybin/MDMA-Assisted Therapy2DModerate60 FPS

Preliminary Clinical Evidence Submission

Early trial results are gathered to support a breakthrough request.

Phase 1/2: Evidence type (placeholder metric)
Preliminary: Endpoint signal (placeholder metric)
Existing therapy: Comparator (placeholder metric)
In progress: Sponsor readiness (placeholder metric)

Building the evidence package

Short placeholder describing early data compilation for the filing.

Breakthrough Designation Request

A formal request is filed with the FDA for expedited review status.

BTD Request: Filing type (placeholder metric)
60 days: Review clock (placeholder metric)
Unmet need: Criteria cited (placeholder metric)
Pre-request: Sponsor meetings (placeholder metric)

Filing the request

Short placeholder describing the designation request submission.

FDA Designation Granted

The FDA grants breakthrough therapy status to the psychedelic candidate.

Granted: Outcome (placeholder metric)
Fast-track: Unlocked benefit (placeholder metric)
Senior staff: Agency contact (placeholder metric)
Announced: Public notice (placeholder metric)

What designation unlocks

Short placeholder describing benefits of the granted status.

Intensive FDA Guidance Meetings

Frequent agency meetings shape trial design and endpoints.

Frequent: Meeting cadence (placeholder metric)
Trial design: Topics (placeholder metric)
Enabled: Rolling review (placeholder metric)
Senior mgmt: Agency involvement (placeholder metric)

Guidance meeting cadence

Short placeholder describing the intensive meeting schedule.

Accelerated Trial Timeline

Phase 2 and 3 trials proceed on a compressed regulatory schedule.

Compressed: Phase 2/3 (placeholder metric)
Rolling: Review type (placeholder metric)
Years: Time saved (placeholder metric)
Accelerated: Approval path (placeholder metric)

Compressed trial execution

Short placeholder describing the accelerated timeline outcome.

Short placeholder highlight summarizing the overall pathway benefit.

⚙ Under the hood

This simulation guides users through the process of obtaining a Breakthrough Therapy Designation from the FDA for psychedelic drugs, highlighting critical steps and requirements.

CanvasBiomedicine

2D · HTML5 Canvas 2D · 60 FPS target · runs fully client-side, no install